The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Issue 35 (31st July 2020)

• Record Type: Journal Article
• Authors: Kochhar, Sonali; Kim, Denny; Excler, Jean-Louis; Condit, Richard C.; Robertson, James S.; Drew, Stephen; Whelan, Mike; Wood, David; Fast, Patricia E.; Gurwith, Marc; Klug, Bettina; Khuri-Bulos, Najwa; Smith, Emily R.; Chen, Robert T
• Is Part Of: Vaccine. Volume 38:Issue 35(2020)
• Page Start: 5734
• Page End: 5739
• Publication Date: 2020-07-31
• Subjects: Brighton Collaboration -- CEPI -- COVID-19 -- Vaccine -- Benefit-risk -- Safety -- Protein -- Recombinant -- Peptide -- Template; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.06.044
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of protein vaccines. This will help key stakeholders to assess potential safety issues and understand the benefit-risk of such a vaccine platform. The structured and standardized assessment provided by the template would also help contribute to improved public acceptance and communication of licensed protein vaccines.